help button home button Am J Pathol Epitomics Buy 2 Antibodies Get 1 Free Special Offer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wisniewski, T.
Right arrow Articles by Frangione, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wisniewski, T.
Right arrow Articles by Frangione, B.

American Journal of Pathology, Vol 147, 238-244, Copyright © 1995 by American Society for Investigative Pathology


REGULAR ARTICLES

Conformational mimicry in Alzheimer's disease. Role of apolipoproteins in amyloidogenesis

T Wisniewski, AA Golabek, E Kida, KE Wisniewski and B Frangione
Department of Pathology, New York University Medical Center, New York 10016, USA.

Several apolipoproteins are known to be closely associated with amyloid fibrillogenesis. Serum amyloid A, apolipoprotein (apo) AII and apo A1 are each deposited as biochemically distinct forms of amyloid. Late- onset Alzheimer's disease is linked to one isotype of apo E, apo E4. Apo E and apo E4 in particular have been shown to modulate amyloid fibril formation by amyloid-beta peptides in vitro. Furthermore, the carboxy terminus of apo E has been shown to be a constituent of plaque amyloid. We show immunohistochemically and electron microscopically the presence of apo A1 in senile plaques. The intact apo A1 can itself form amyloid-like fibrils in vitro that are Congo Red positive. We propose that some proteins when misfolded can propagate this misfolding to identical units, either autocatalytically or to other proteins that are induced to fold into the same abnormal conformation. This conformational mimicry may initiate and/or augment fibrillogenesis in Alzheimer's disease.


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
K. Abildayeva, J. F. P. Berbee, A. Blokland, P. J. Jansen, F. J. Hoek, O. Meijer, D. Lutjohann, T. Gautier, T. Pillot, J. De Vente, et al.
Human apolipoprotein C-I expression in mice impairs learning and memory functions
J. Lipid Res., April 1, 2008; 49(4): 856 - 869.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. A. Liz, C. M. Gomes, M. J. Saraiva, and M. M. Sousa
ApoA-I cleaved by transthyretin has reduced ability to promote cholesterol efflux and increased amyloidogenicity
J. Lipid Res., November 1, 2007; 48(11): 2385 - 2395.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
N. Scarmeas
Invited Commentary: Lipoproteins and Dementia--Is It the Apolipoprotein A-I?
Am. J. Epidemiol., May 1, 2007; 165(9): 993 - 997.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
N. Sakata, Y. Hoshii, T. Nakamura, M. Kiyama, H. Arai, M. Omoto, M. Morimatsu, and T. Ishihara
Colocalization of Apolipoprotein AI in Various Kinds of Systemic Amyloidosis
J. Histochem. Cytochem., February 1, 2005; 53(2): 237 - 242.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. A. Medeiros, T. Khan, J. B. El Khoury, C. L. L. Pham, D. M. Hatters, G. J. Howlett, R. Lopez, K. D. O'Brien, and K. J. Moore
Fibrillar Amyloid Protein Present in Atheroma Activates CD36 Signal Transduction
J. Biol. Chem., March 12, 2004; 279(11): 10643 - 10648.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Andreola, V. Bellotti, S. Giorgetti, P. Mangione, L. Obici, M. Stoppini, J. Torres, E. Monzani, G. Merlini, and M. Sunde
Conformational Switching and Fibrillogenesis in the Amyloidogenic Fragment of Apolipoprotein A-I
J. Biol. Chem., January 17, 2003; 278(4): 2444 - 2451.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J. Lotharius and P. Brundin
Impaired dopamine storage resulting from {alpha}-synuclein mutations may contribute to the pathogenesis of Parkinson's disease
Hum. Mol. Genet., October 1, 2002; 11(20): 2395 - 2407.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. M. Hatters, A. P. Minton, and G. J. Howlett
Macromolecular Crowding Accelerates Amyloid Formation by Human Apolipoprotein C-II
J. Biol. Chem., March 1, 2002; 277(10): 7824 - 7830.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
K. Nishida, A. J Quantock, A. Dota, N.-H. Choi-Miura, and S. Kinoshita
Apolipoproteins J and E co-localise with amyloid in gelatinous drop-like and lattice type I corneal dystrophies
Br. J. Ophthalmol., October 1, 1999; 83(10): 1178 - 1182.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. A. Golabek, C. Soto, T. Vogel, and T. Wisniewski
The Interaction between Apolipoprotein E and Alzheimer's Amyloid beta-Peptide Is Dependent on beta-Peptide Conformation
J. Biol. Chem., May 3, 1996; 271(18): 10602 - 10606.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. M. Hatters, R. A. Lindner, J. A. Carver, and G. J. Howlett
The Molecular Chaperone, alpha -Crystallin, Inhibits Amyloid Formation by Apolipoprotein C-II
J. Biol. Chem., August 31, 2001; 276(36): 33755 - 33761.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Society for Investigative Pathology.